PATENT CLAIM ANALYSIS

Application Number: 16418794
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["424", "093200"]

Abstract:
The inventive technology relates to novel paratransgenic strategies for the control of pathogens. The inventive technology may specifically include a novel paratransgenic system configured to deliver one or more inhibitory RNA molecules to pathogen/disease-transmitting organisms. In a preferred embodiment, the invention may include one or more genetically engineered enteric bacteria configured to deliver one or more interfering RNA molecules to pathogen/disease-transmitting mosquitos.

Claim (Index 145):
The system of  claim 141 , wherein the genetically modified mosquito symbiotic bacteria further expresses a heterologous nucleotide encoding at least one of the following: a VrrA small-non-coding RNA, SIDa, SID2, Ago2, YmdB, HlyA, a sec-secretory signal peptide, a Tat-secretory signal peptide, a cell-penetrating peptide, and a dsRNA-binding protein.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 1.65
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15922904', '15709890', '15601446', '15507332', '13545604']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6306079499447598
- 35 USC 102 Novelty (BERT): 0.6533614258436733
- Combined Prediction Score: 0.6328832975346512
- Mean Citation Score: 351.70745
- Max Citation Score: 761.12585
- Similarity Product: 568.6188818083763

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test